Inventor · disambiguated record
Kaustav Biswas
Also filed as: BISWAS KAUSTAV
16 granted patents·7 pending applications·92 citations·filing 2002–2024
91Inventor score
Top patents by PatentIndex Score
23 records- 0190US9090593B2Bicyclic compounds as Pim inhibitorsWANG HUI-LING·Filed 2011·Granted Jul 28, 2015·26 cites·51 claims
- 0288US7854934B2Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereofSLOAN KETTERING INST CANCER·Filed 2002·Granted Dec 21, 2010·38 cites·76 claims
- 0387US7635715B2Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereofAMGEN INC·Filed 2007·Granted Dec 22, 2009·7 cites·50 claims
- 0482US9096527B2TRPM8 antagonists and their use in treatmentsAMGEN INC·Filed 2014·Granted Aug 4, 2015·5 cites·38 claims
- 0577US8012968B2Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereofAMGEN INC·Filed 2010·Granted Sep 6, 2011·4 cites·15 claims
- 0676US7728130B2Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activityAMGEN INC·Filed 2006·Granted Jun 1, 2010·2 cites·6 claims
- 0774US8048892B2Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereofAMGEN INC·Filed 2007·Granted Nov 1, 2011·2 cites·50 claims
- 0871US8097620B2Diazaquinolones that inhibit prolyl hydroxylase activityALLEN JENNIFER R·Filed 2008·Granted Jan 17, 2012·1 cites·62 claims
- 0970US7662811B21,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of useAMGEN INC·Filed 2005·Granted Feb 16, 2010·1 cites·13 claims
- 1068US8017626B2Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereofAMGEN INC·Filed 2010·Granted Sep 13, 2011·1 cites·16 claims
- 1167US7393852B2Piperazine derivatives and methods of useAMGEN INC·Filed 2004·Granted Jul 1, 2008·3 cites·42 claims
- 1265US7425631B2Compounds and methods of useAMGEN INC·Filed 2004·Granted Sep 16, 2008·2 cites·6 claims
- 1363US2024287138A1Cyclic peptides for inhibiting tnf receptor 1 activityMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1461US7928139B2Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereofAMGEN INC·Filed 2009·Granted Apr 19, 2011·0 cites·30 claims
- 1557US2009048224A1Compounds and methods of useAMGEN INC·Filed 2008·Application pending·0 cites
- 1654US2009054460A1Piperazine derivatives and methods of useCHEN JIAN J·Filed 2008·Application pending·0 cites
- 1751US2011118234A1Urea Compounds as Gamma Secretase ModulatorsBISWAS KAUSTAV·Filed 2009·Application pending·0 cites
- 1849US8759532B2Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitorsAMGEN INC·Filed 2012·Granted Jun 24, 2014·0 cites·80 claims
- 1948US2015031668A1Chroman derivatives as trpm8 inhibitorsAMGEN INC·Filed 2014·Application pending·0 cites
- 2046US8952009B2Chroman derivatives as TRPM8 inhibitorsAMGEN INC·Filed 2013·Granted Feb 10, 2015·0 cites·57 claims
- 2144US2006111347A1Substituted sulfones and methods of useAMGEN INC·Filed 2005·Application pending·0 cites
- 2243US10344060B2Potent and selective inhibitors of Nav1.7AMGEN INC·Filed 2014·Granted Jul 9, 2019·0 cites·25 claims
- 2333US2003176368A1Synthesis of epothilones, intermediates thereto and analogues thereofFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kaustav Biswas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →